The role of Raf kinase inhibitor protein (RKIP) in health and disease
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (6) , 1049-1053
- https://doi.org/10.1016/j.bcp.2004.04.024
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R01-CA098513)
This publication has 33 references indexed in Scilit:
- The Hippocampal Cholinergic Neurostimulating Peptide, the N-terminal Fragment of the Secreted Phosphatidylethanolamine-binding Protein, Possesses a New Biological Activity on Cardiac PhysiologyPublished by Elsevier ,2004
- Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2Nature, 2003
- A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C β inhibitionAmerican Journal of Kidney Diseases, 2003
- Metastasis suppressor pathways—an evolving paradigmCancer Letters, 2003
- Practical Bioinformatics for ProteomicsPublished by S. Karger AG ,2003
- Purification and characterization of a basic 23 kDa cytosolic protein from bovine brainPublished by Elsevier ,2002
- Raf Kinase Inhibitor Protein Interacts with NF-κB-Inducing Kinase and TAK1 and Inhibits NF-κB ActivationMolecular and Cellular Biology, 2001
- Possible implication of hippocampal cholinergic neurostimulating peptide (HCNP)‐related components in Hirano body formationNeuropathology and Applied Neurobiology, 1996
- A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding proteinGene, 1994
- Localization of the Novel Neuropolypeptide h3 in Subsets of Tissues from Different SpeciesJournal of Neurochemistry, 1988